1
Douglas J Allen, Kirk W Johnson, Robert S Nevin: Hydrophilic polyurethane membranes for electrochemical glucose sensors. Eli Lilly and Company, Woodward Emhardt Naughton Moriarty & McNett, June 21, 1994: US05322063 (772 worldwide citation)

Homogeneous membranes permeable to oxygen and glucose composed of hydrophilic polyurethanes that are capable of absorbing from 10 to 50% of their dry weight of water. Variations in the composition of the hydrophilic polyurethanes make possible the fabrication of membranes in which the ratios of the ...


2
Kirk W Johnson, John J Mastrototaro: Techniques to improve the performance of electrochemical sensors. Eli Lilly and Company, Woodard Emhardt Naughton Moriarty & McNett, May 2, 1995: US05411647 (744 worldwide citation)

A method of improving the utility of electrochemical glucose sensors by decreasing either or both their settling time and their sensitivity to interfering compounds. In particular, the settling time of an electrochemical glucose sensor is improved by pretreating the operating electrode with a negati ...


3
James W Heller, David Lipson, Kirk W Johnson: Thin film electrical component. Eli Lilly and Company, Douglas J Taylor, Leroy Whitaker, April 28, 1992: US05108819 (432 worldwide citation)

A biocompatible thin film electrical component is configured for use in a human body or other ionic liquid environment. A polyimide substrate is bonded to a glass carrier plate sized for handling by automatic equipment and a multiple-layer metal conductor is deposited on the substrate and patterned ...


4
Robert E Krocker, Terence D Baier, Merle A Renaud, Paul C Rentmeester, Robert M Swanson, Patrick J Wilson, Kirk W Johnson: HVAC service tool with internet capability. Trane International, William O Driscoll, June 3, 2008: US07383158 (93 worldwide citation)

A system for servicing a computer controlled machine comprising: a computer controlled machine including a device operable to perform a function, a controller controlling the operation of that device, and a data access port for transferring data and commands from the controller; and a service tool o ...


5
Kirk W Johnson: Immobolization of biomolecules by enhanced electrophoretic precipitation. Eli Lilly and Company, Douglas J Taylor, Leroy Whitaker, November 24, 1992: US05166063 (42 worldwide citation)

The present invention provides a method for immobilizing biomolecules on a conductive substrate to produce a biosensor.


6
Sandra Ann Filla, Kirk W Johnson, Lee A Phebus, John Mehnert Schaus: 5-HT.sub.1F agonists. Eli Lilly and Company, Robert D Titus, David E Boone, October 6, 1998: US05817671 (22 worldwide citation)

This invention provides 5-HT.sub.1F agonists of Formula I: ##STR1## where A--B, X, and R are as defined in the specification. The invention also encompasses pharmaceutical formulations employing compounds of Formula I as well as methods of treating conditions associated with 5-HT.sub.1F activation e ...


7
James E Audia, Marlene L Cohen, Kirk W Johnson, Lee A Phebus, Theresa Branchek: 5-HT.sub.1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine. Eli Lilly and Company, Robert D Titus, David E Boone, December 16, 1997: US05698571 (12 worldwide citation)

The present invention provides a method for the treatment of migraine with compounds or compositions that are selective agonists of 5-HT.sub.1F receptors relative to other serotonin receptors that produce unwanted effects like vasoconstriction. The neurogenic meningeal extravasation that leads to th ...


8
John M Nuss, Stephen D Harrison, David B Ring, Rustum S Boyce, Sean P Brown, Dane A Goff, Kirk W Johnson, Keith B Pfister, Savithri Ramurthy, Paul A Renhowe, Lynn Seely, Sharadha Subramanian, Allan S Wagman, Xiaohui A Zhou: Inhibitors of glycogen synthase kinase 3. Chiron Corporation, Dennis K Shelton, Young J Suh, Alisa A Harbin, May 2, 2006: US07037918 (11 worldwide citation)

New pyrimidine or pyridine based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combinat ...


9
John M Nuss, Stephen D Harrison, David B Ring, Rustum S Boyce, Sean P Brown, Dane A Goff, Kirk W Johnson, Keith B Pfister, Savithri Ramurthy, Paul A Renhowe, Lynn Seely, Sharadha Subramanian, Allan S Wagman, Xiaohui A Zhou: Inhibitors of glycogen synthase kinase 3. Chiron Corporation, Dennis K Shelton, David P Lentini, Robert P Blackburn, December 3, 2002: US06489344 (11 worldwide citation)

New pyrimidine or pyridine based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combinat ...


10
Jurg M Sommer, Raymond A Chavez, Kirk W Johnson, Linda May Rothblum Watkins: Mutant IL-10. The Regents of the University of Colorado, Robins & Pasternak, July 6, 2010: US07749490 (9 worldwide citation)

IL-10 sequence variants are disclosed that retain the therapeutically desirable anti-inflammatory properties of wild-type IL-10 but do not retain the hemoatopoeitic cell regulatory and cell proliferative activities. The mutant IL-10 polypeptides of the invention are used in methods of treating disea ...



Click the thumbnails below to visualize the patent trend.